Clinical trial
Effect of Rosiglitazone on Peritoneal Cytokines in Women With Endometriosis
NCT00121953 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Withdrawn
Key facts
| NCT number | NCT00121953 |
|---|---|
| Title | Effect of Rosiglitazone on Peritoneal Cytokines in Women With Endometriosis |
| Official title | Endometriosis: Immunomodulation |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Status | Withdrawn |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Endometriosis |
| Intervention type | Drug |
| Interventions | Rosiglitazone |
| Enrollment | 0 |
| Start date | Jul 1, 2005 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jul 21, 2005 |
| Last update posted | Oct 17, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: